PPT1

palmitoyl-protein thioesterase 1, the group of Depalmitoylases

Basic information

Region (hg38): 1:40072710-40097260

Previous symbols: [ "PPT" ]

Links

ENSG00000131238NCBI:5538OMIM:600722HGNC:9325Uniprot:P50897AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • neuronal ceroid lipofuscinosis 1 (Definitive), mode of inheritance: AR
  • neuronal ceroid lipofuscinosis 1 (Definitive), mode of inheritance: AR
  • neuronal ceroid lipofuscinosis 1 (Strong), mode of inheritance: AR
  • neuronal ceroid lipofuscinosis 1 (Supportive), mode of inheritance: AR
  • neuronal ceroid lipofuscinosis 1 (Strong), mode of inheritance: AR
  • neuronal ceroid lipofuscinosis 1 (Definitive), mode of inheritance: AR
  • neuronal ceroid lipofuscinosis (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Ceroid lipofuscinosis, neuronal, 1ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Neurologic; Ophthalmologic5706364; 4121459; 4698309; 6890163; 7637805; 9664077; 9425237; 9535296; 11506414; 15965709; 17261688; 21235444; 21990111

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PPT1 gene.

  • Neuronal_ceroid_lipofuscinosis_1 (617 variants)
  • not_provided (109 variants)
  • Inborn_genetic_diseases (60 variants)
  • not_specified (45 variants)
  • Neuronal_ceroid_lipofuscinosis (20 variants)
  • PPT1-related_disorder (8 variants)
  • Intellectual_disability (2 variants)
  • Retinitis_pigmentosa (2 variants)
  • See_cases (1 variants)
  • Central_core_myopathy (1 variants)
  • Abnormality_of_the_nervous_system (1 variants)
  • Neuronal_Ceroid-Lipofuscinosis,_Recessive (1 variants)
  • Spastic_ataxia (1 variants)
  • Neurodevelopmental_disorder_with_dysmorphic_facies_and_distal_limb_anomalies (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPT1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000310.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
7
clinvar
141
clinvar
148
missense
11
clinvar
40
clinvar
167
clinvar
2
clinvar
2
clinvar
222
nonsense
15
clinvar
15
clinvar
30
start loss
2
3
5
frameshift
28
clinvar
27
clinvar
55
splice donor/acceptor (+/-2bp)
14
clinvar
21
clinvar
35
Total 70 106 174 143 2

Highest pathogenic variant AF is 0.000453566

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PPT1protein_codingprotein_codingENST00000433473 924997
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00004860.96812564501031257480.000410
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.03391631640.9930.000008852006
Missense in Polyphen5161.2620.83249817
Synonymous-1.107462.91.180.00000343582
Loss of Function1.941019.20.5219.90e-7210

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002750.000275
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.0008190.000818
Middle Eastern0.00005440.0000544
South Asian0.00006530.0000653
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Removes thioester-linked fatty acyl groups such as palmitate from modified cysteine residues in proteins or peptides during lysosomal degradation. Prefers acyl chain lengths of 14 to 18 carbons (PubMed:8816748). {ECO:0000269|PubMed:8816748}.;
Disease
DISEASE: Ceroid lipofuscinosis, neuronal, 1 (CLN1) [MIM:256730]: A form of neuronal ceroid lipofuscinosis with variable age at onset. Infantile, late-infantile, juvenile, and adult onset have been reported. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. The lipopigment pattern seen most often in CLN1 is referred to as granular osmiophilic deposits (GROD). {ECO:0000269|PubMed:11506414, ECO:0000269|PubMed:19201763, ECO:0000269|PubMed:19941651, ECO:0000269|PubMed:21990111, ECO:0000269|PubMed:7637805, ECO:0000269|PubMed:9425237, ECO:0000269|PubMed:9664077}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Lysosome - Homo sapiens (human);Fatty acid elongation - Homo sapiens (human);Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD);Fatty Acid Elongation In Mitochondria;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Metabolism;Fatty acid metabolism (Consensus)

Recessive Scores

pRec
0.583

Intolerance Scores

loftool
0.204
rvis_EVS
-0.16
rvis_percentile_EVS
41.91

Haploinsufficiency Scores

pHI
0.339
hipred
N
hipred_score
0.253
ghis
0.537

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.965

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ppt1
Phenotype
growth/size/body region phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; pigmentation phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; skeleton phenotype;

Gene ontology

Biological process
protein depalmitoylation;receptor-mediated endocytosis;pinocytosis;lysosomal lumen acidification;neurotransmitter secretion;nervous system development;brain development;visual perception;grooming behavior;associative learning;adult locomotory behavior;protein transport;lipid catabolic process;sphingolipid catabolic process;protein catabolic process;negative regulation of cell growth;membrane raft organization;regulation of phospholipase A2 activity;negative regulation of apoptotic process;negative regulation of neuron apoptotic process;cellular protein catabolic process;fatty-acyl-CoA biosynthetic process;positive regulation of receptor-mediated endocytosis;positive regulation of pinocytosis;neuron development;regulation of synapse structure or activity;response to stimulus;cofactor transport;cofactor metabolic process
Cellular component
extracellular region;nucleus;lysosome;Golgi apparatus;cytosol;synaptic vesicle;membrane;axon;dendrite;neuronal cell body;lysosomal lumen;membrane raft;extracellular exosome
Molecular function
protein binding;palmitoyl-(protein) hydrolase activity;palmitoyl-CoA hydrolase activity